Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Are there unmet needs in acid suppression?

¹Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands. g.n.tytgat@amc.uva.nl

Best Practice & Research. Clinical Gastroenterology

|December 14, 2004

Summary

Proton-pump inhibitors (PPIs) improve acid control but often fail to provide 24-hour relief for GERD patients. Achieving complete acid suppression remains a challenge, impacting symptom control and patient satisfaction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Gastro-highlights 2012].

Praxis·2013

Same author

Etiopathogenetic principles and peptic ulcer disease classification.

Digestive diseases (Basel, Switzerland)·2011

Same author

Endosonography in gastroenterology. Preface.

Best practice & research. Clinical gastroenterology·2009

Same author

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Digestion·2009

Same author

Endoscopy.

Best practice & research. Clinical gastroenterology·2008

Same author

Gastric hypersensitivity induced by oesophageal acid infusion in healthy volunteers.

Neurogastroenterology and motility·2008

Area of Science:

Gastroenterology
Pharmacology

Background:

Proton-pump inhibitors (PPIs) have significantly advanced gastric acid secretion control, particularly for gastroesophageal reflux disease (GERD).
Despite PPI efficacy, unmet clinical needs persist regarding complete 24-hour acid suppression and optimal patient management.

Purpose of the Study:

To highlight the limitations of current oral PPI therapy in achieving full 24-hour gastric acid control.
To address the challenges in managing specific conditions like nocturnal acid breakthrough and Non-Erosive Reflux Disease (NERD).

Main Methods:

Review of clinical outcomes and patient-reported symptoms associated with PPI therapy.
Analysis of challenges in achieving sustained acid control in various patient populations.

Main Results:

Current oral PPIs struggle to provide complete 24-hour acid suppression, especially in healthy gastric mucosa and specific conditions like esophageal columnar metaplasia.
Nocturnal acid breakthrough and suboptimal symptom control are common in GERD patients, necessitating additional treatments.
PPIs are not ideal for on-demand therapy in NERD, and abrupt cessation can lead to rebound acid secretion and relapse.

Conclusions:

There is a need for improved acid suppressant therapies that offer complete 24-hour control for individual patient needs.
Addressing nocturnal acid breakthrough and enhancing on-demand therapy are crucial for better GERD and NERD management.
Strategies to mitigate rebound acid secretion are necessary to prevent early symptomatic relapse after PPI discontinuation.

Related Experiment Videos